98%
921
2 minutes
20
Objective: To understand how methylphenidate (MPH) is used in youth with traumatic brain injury (TBI) during inpatient pediatric rehabilitation.
Setting: Inpatient pediatric rehabilitation.
Participants: In total, 234 children with TBI; 62 of whom received MPH and 172 who did not. Patients were on average 11.6 years of age (range, 2 months to 21 years); 88 of 234 were female; the most common mechanism of injury was motor vehicle collision (49%); median (IQR) acute hospital length of stay (LOS) and inpatient rehabilitation LOS were 16 (10-29) and 23 (14-39), respectively; 51 of 234 were in a disorder of consciousness cognitive state at time of inpatient rehabilitation admission.
Design: Multicenter, retrospective medical record review.
Main Measures: Patient demographic data, time to inpatient pediatric rehabilitation admission (TTA), cognitive state, MPH dosing (mg/kg/day).
Results: Patients who received MPH were older (P = .011); TTA was significantly longer in patients who received MPH than those who did not (P =.002). The lowest recorded dose range by weight was 0.05 to 0.89 mg/kg/d, representing an 18-fold difference; the weight-based range for the maximum dose was 0.11 to 0.97 mg/kg/d, a 9-fold difference. Patients in lower cognitive states at admission (P = .001) and at discharge (P = .030) were more likely to receive MPH. Five patients had side effects known to be associated with MPH; no serious adverse events were reported.
Conclusion: This multicenter study indicates that there is variable use of MPH during acute inpatient rehabilitation for children with TBI. Children who receive MPH tend to be older with lower cognitive states. Dosing practices are likely consistent with underdosing. Clinical indications for MPH use during inpatient pediatric rehabilitation should be better defined. The use of MPH, as well as its combination with other medications and treatments, during inpatient rehabilitation needs to be further explored.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11076004 | PMC |
http://dx.doi.org/10.1097/HTR.0000000000000889 | DOI Listing |
Am J Cardiol
September 2025
Istituti Clinici Scientifici Maugeri IRCCS, Institute of Bari, Bari, Italy.
Whether risk of death interacts with change in six-minute walking test (6MWT) distance after cardiac rehabilitation (CR) on heart failure (HF) prognosis is unknown. We studied 1,569 patients with HF admitted to six inpatient CR units. A 6MWT was performed at admission to and at discharge from CR.
View Article and Find Full Text PDFJ Opioid Manag
September 2025
Austin Health, Heidelberg, Australia.
Background: Opioid prescribing to post-operative patients in the acute hospital setting is well described; however, little is known about use of opioids in inpatient rehabilitation (IPR) settings. Understanding how opioids are prescribed across all inpatient settings is important to optimize opioid stewardship. The aim of this study was to determine the percentage of post-operative orthopedic patients prescribed opioids and prescribing patterns on discharge from an IPR ward.
View Article and Find Full Text PDFCureus
August 2025
Rehabilitation, Hikari Hospital, Otsu, JPN.
Background and purpose To investigate the usefulness of the revised Ability for Basic Movement Scale (ABMS II) for chronic-phase hospitalized patients, whether admitted owing to illness or injury. Methods A retrospective cohort of 176 consecutively admitted chronic care inpatients who underwent rehabilitation therapy between April 2021 and March 2023 was analyzed. Patients who died during admission, who were discharged within one month, or who had insufficient clinical data were excluded.
View Article and Find Full Text PDFAm J Phys Med Rehabil
September 2025
Patient participation in therapy sessions during inpatient rehabilitation is essential to maximize recovery. While specific reasons for missed therapies have not been studied in the brain injury population, individuals with brain injuries are often medically complex, which may impact participation. This quality improvement (QI) study aimed to deepen the understanding of reasons for missed therapy and design an intervention to improve therapy participation in an inpatient brain injury rehabilitation unit.
View Article and Find Full Text PDFAnn Vasc Surg
September 2025
Service de Médecine Physique et Réadaptation Locomotrice et Respiratoire, CHU Nantes, Nantes Université, 85 rue Saint Jacques, 44093 Nantes, Cedex 1, France; Service de Médecine du Sport, CHU Nantes, Nantes Université, 85 rue Saint Jacques, 44093 Nantes, Cedex 1, France; Institut Régional de M
Objectives: Neurogenic thoracic outlet syndrome (NTOS) is due to the compression of the brachial plexus and is responsible for upper-limb pain, strength loss and fatigability, which are responsible for daily-life impairment. We assessed prospectively the effect of a 3-week inpatient rehabilitation on upper-limb strength and endurance, and to assess pain and function in patients with NTOS.
Methods: 220 patients with NTOS addressed to rehabilitation were included.